Hi, can you please add the source also? It will be useful for everyone if we can start adding more details to the guidance.

Fineotex Chemical Limited – Standalone and Consolidated Business Performance Highlights Q2-FY24

Standalone Business – Q2-FY24 vs Q2-FY23:

1. Revenue Growth: Fineotex, a specialty chemical producing public-listed company, reports a substantial increase in Q2-FY24 revenue, reaching Rs. 10,442 Lakhs, reflecting a robust growth of 36.88% compared to Rs. 7,629 Lakhs in Q2-FY23.
2. Profit Surge: The Profit after tax (PAT) for the quarter stands at Rs. 2,741 Lakhs, marking an impressive growth of 128.88% from Rs. 1,197 Lakhs in the same period last year.
3. Operational EBITDA: The Operational EBITDA registers a noteworthy growth of 96.33%, reaching Rs. 2,797 Lakhs in Q2-FY24 compared to Rs. 1,424 Lakhs in Q2-FY23.

Standalone Business – H1-FY24 vs H1-FY23:

1. Revenue Expansion: Fineotex continues its upward trajectory in H1-FY24, with revenue from operations surging to Rs. 19,253 Lakhs, exhibiting a robust growth of 40.71% from Rs. 13,683 Lakhs in H1-FY23.
2. Profit Momentum: The Profit after tax (PAT) for the first half of the fiscal year reaches Rs. 5,000 Lakhs, demonstrating a remarkable growth of 113.56% from Rs. 2,341 Lakhs in H1-FY23.
3. Operational EBITDA: The Operational EBITDA for H1-FY24 stands at Rs. 5,022 Lakhs, showcasing a substantial growth of 109.05% from Rs. 2,402 Lakhs in H1-FY23.

Consolidated Business – Q2-FY24 vs Q2-FY23:

1. Profit Uplift: In the consolidated domain, the Profit after tax (PAT) witnesses a growth of 51.61%, reaching Rs. 3,150 Lakhs in Q2-FY24 from Rs. 2,077 Lakhs in Q2-FY23.
2. Operational EBITDA Expansion: The Operational EBITDA for the consolidated business marks an increase of 52.27%, reaching Rs. 3,821 Lakhs in Q2-FY24 from Rs. 2,509 Lakhs in Q2-FY23.

Consolidated Business – H1-FY24 vs H1-FY23:

1. Profit Growth: The Profit after tax (PAT) for the consolidated business in H1-FY24 registers a growth of 40.28%, reaching Rs. 5,762 Lakhs from Rs. 4,108 Lakhs in H1-FY23.

Additional Highlights:

1. Volume Growth: The consolidated business witnesses a substantial year-on-year volume growth of 43.42%.
2. Cash Flow Efficiency: The cash flow from operation (CFO) to EBITDA ratio for H1-FY24 stands at an impressive 80.72%.
3. Return on Capital Employed (ROCE): The consolidated ROCE for H1-FY24 is reported at 36.38%.
4. Return on Equity (ROE): The consolidated ROE for H1-FY24 stands at 30.31%.

Radiant Cash Management Services Limited (RCMS) Ventures into Fintech with Acemoney Acquisition

Overview: RCMS, a prominent financial entity, has unveiled its strategic move into the fintech domain through the acquisition of a majority stake in Acemoney, a leading Kochi-based fintech company. The Board of Directors at RCMS has granted approval for the definitive agreement, signaling the onset of a significant collaboration.

Acquisition Details:

• Stake Acquisition: RCMS will acquire approximately 56.93% of Acemoney in an all-cash deal, positioning itself to harness the potential of digital transactions in Tier 3+ regions.
• Strategic Value: Acemoney specializes in providing advanced digital banking solutions tailored for retail outlets, cooperative banks, and cooperative societies in rural areas. This expertise aligns with RCMS’s objective to offer an innovative “phygital” platform, seamlessly integrating cash and digital banking services.

Founders’ Vision:

• Founders: Founded by Mr. Jimmin James Kurichiyil and Ms. Nimisha J. Vadakkan, Acemoney is on a mission to extend digital banking solutions to the vast rural population recently integrated into the banking system.
• Retained Stake: Post-acquisition, the founders will retain a significant minority stake in Acemoney, actively contributing to the company’s rapid growth.

Strategic Positioning:

• Growth Catalyst: Col. David Devasahayam, Chairman and Managing Director of RCMS, emphasizes the strategic fit of Acemoney, foreseeing substantial growth potential. The collaboration aims to capitalize on the surge in digital transactions across the nation.
• Market Scope: With nearly 100,000 rural cooperatives and a large population transitioning from physical to digital banking, the partnership seeks to play a pivotal role in financial inclusion and unlock growth opportunities.

Q: why reporting is done in XBRL format worldwide

XBRL is used for reporting worldwide because it offers a number of advantages over traditional reporting methods, including:

• Accuracy: XBRL data is machine-readable, which means that it can be easily checked for accuracy and completeness. This is important for regulators, investors, and other users of financial information.
• Consistency: XBRL reports are consistent in format and structure, regardless of the reporting organization. This makes it easier for users to compare data from different companies and industries.
• Efficiency: XBRL reports can be processed and analyzed much more quickly and efficiently than traditional reports. This is because XBRL data can be automatically extracted and aggregated by software applications.
• Interoperability: XBRL reports can be easily exchanged between different software systems. This makes it possible for users to access and analyze XBRL data from anywhere in the world.

As a result of these advantages, XBRL has been adopted by regulators and companies in over 100 countries around the world.

Here are some specific examples of how XBRL is being used for reporting worldwide:

• The US Securities and Exchange Commission (SEC) requires all public companies in the US to file their financial statements in XBRL format. This helps the SEC to more easily and efficiently monitor the financial health of public companies.
• The European Union (EU) has mandated the use of XBRL for reporting by certain types of companies, such as banks and insurance companies. This helps the EU to promote financial transparency and reduce the risk of financial crises.
• The International Accounting Standards Board (IASB) has developed a global taxonomy for XBRL reporting. This taxonomy is used by many countries around the world to standardize the reporting of financial information.

In addition to financial reporting, XBRL is also being used for reporting in other areas, such as environmental reporting, sustainability reporting, and risk reporting.

Overall, XBRL is a powerful tool that can be used to improve the accuracy, consistency, efficiency, and interoperability of reporting worldwide.

**HealthCare Global Enterprises Ltd. (HCG) Unveils Strong Q2FY24 Results and Operational Highlights! **

Financial Snapshot:

• Q2FY24 Revenue: ₹4,869 Mn., a substantial 16% YoY growth.
• Q2FY24 EBITDA: ₹864 Mn., a robust 14% YoY increase.
• Q2FY24 PAT: ₹136 Mn., showing significant growth.
• Revenue Breakup: Mature Centers – ₹3,477 Mn. (13% YoY), Emerging Centers – ₹1,216 Mn. (29% YoY).
• EBITDA Breakup: Mature Centers – ₹832 Mn. (7% YoY), Emerging Centers – ₹122 Mn. (23% YoY).

Half-Yearly Performance (H1FY24):

• H1FY24 Revenue: ₹9,476 Mn., a strong 14% YoY growth.
• H1FY24 EBITDA: ₹1,629 Mn., reflecting a 15% YoY increase.
• H1FY24 PAT: ₹212 Mn., a remarkable 58% YoY growth.

Operational Highlights for Q2FY24:

• ARPOB: ₹42,054, up from ₹36,914 in Q2 FY23.
• AOR: 63.6%, maintaining strong operational efficiency.
• RoCE (Q2FY24 Annualized):
  • Mature Centers: 21.2%, RoCE pre-corporate allocations at 25.5%.
  • Emerging Centers: -3.9%, RoCE pre-corporate allocations at -0.8%.
• High Double-Digit Growth: Key markets like Kolkata and Mumbai grew by 42% and 41% YoY.
• International Operations: Witnesses robust growth at 175% YoY.

Infrastructure Enhancement (Q2FY24):

• New Additions: 3 LINAC machines, 3 Robotics surgery machines in Mumbai, Kolkata & Baroda.

Leadership Insights:

• Dr. B.S. Ajaikumar, Executive Chairman: Highlights strides in outcome-driven cancer care, groundbreaking studies, and the acquisition of SRJ CBCC Cancer Hospital in Indore.
• Mr. Raj Gore, CEO: Emphasizes the commitment to patient outreach, capacity enhancement, and integration of acquired hospitals to extend cancer care services.